Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002294 · ClinicalTrials.gov registry record · NA
A Study of Fluconazole in the Treatment of Cryptococcal Meningitis in Patients With AIDS
A NA study, sponsored by Pfizer.
- Completed
- Registry status
- NA
- Development phase
NCT00002294: Completed NA study, sponsored by Pfizer.
NCT00002294 is a NA study that has completed, run by Pfizer. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00002294, a NA study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- NA
- Development phase
Study Summary
To compare the safety and effectiveness of fluconazole with that of placebo as maintenance treatment for preventing the relapse of cryptococcal meningitis in patients with AIDS.
Interventions
- DRUG Fluconazole
Trial Details
| Field | Value |
|---|---|
| Phase | NA |
What the finished NCT00002294 record still lists
NCT00002294 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which Fluconazole is the first listed.
NCT00002294 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00002294 about?
NCT00002294 is a clinical study titled "A Study of Fluconazole in the Treatment of Cryptococcal Meningitis in Patients With AIDS". To compare the safety and effectiveness of fluconazole with that of placebo as maintenance treatment for preventing the relapse of cryptococcal meningitis in patients with AIDS.
What is the current status of trial NCT00002294?
This trial is currently completed. It is a NA study.
What interventions are being tested in trial NCT00002294?
The interventions under investigation include: Fluconazole (DRUG).
Who is sponsoring clinical trial NCT00002294?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.